 | • レポートコード：MRC2-11QY04409 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は向精神薬のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬）市場規模、用途別（病院薬局、ドラッグストア、小売店、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別向精神薬の競争状況、市場シェア ・世界の向精神薬市場：種類別市場規模 2015年-2020年（抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬） ・世界の向精神薬市場：種類別市場規模予測 2021年-2026年（抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬） ・世界の向精神薬市場：用途別市場規模 2015年-2020年（病院薬局、ドラッグストア、小売店、Eコマース） ・世界の向精神薬市場：用途別市場規模予測 2021年-2026年（病院薬局、ドラッグストア、小売店、Eコマース） ・北米の向精神薬市場分析：米国、カナダ ・ヨーロッパの向精神薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの向精神薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の向精神薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの向精神薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceuticals、Novartis、Mylan、AstraZeneca、Sun Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior.
The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of mental disorders.
Market Analysis and Insights: Global Psychotropic Pharmaceuticals Market
The global Psychotropic Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Psychotropic Pharmaceuticals Scope and Market Size
Psychotropic Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psychotropic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Teva Pharmaceuticals
Novartis
Mylan
AstraZeneca
Sun Pharmaceuticals
…
Market segment by Type, the product can be split into
Anti-Depressants
Anti-Psychotics
Stimulants
Anxiolytics
Mood Stabilizers
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psychotropic Pharmaceuticals Revenue
1.4 Market by Type
1.4.1 Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Depressants
1.4.3 Anti-Psychotics
1.4.4 Stimulants
1.4.5 Anxiolytics
1.4.6 Mood Stabilizers
1.5 Market by Application
1.5.1 Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Psychotropic Pharmaceuticals Market Perspective (2015-2026)
2.2 Global Psychotropic Pharmaceuticals Growth Trends by Regions
2.2.1 Psychotropic Pharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psychotropic Pharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Psychotropic Pharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Psychotropic Pharmaceuticals Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Psychotropic Pharmaceuticals Players by Market Size
3.1.1 Global Top Psychotropic Pharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Psychotropic Pharmaceuticals Revenue Market Share by Players (2015-2020)
3.1.3 Global Psychotropic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psychotropic Pharmaceuticals Market Concentration Ratio
3.2.1 Global Psychotropic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Psychotropic Pharmaceuticals Revenue in 2019
3.3 Psychotropic Pharmaceuticals Key Players Head office and Area Served
3.4 Key Players Psychotropic Pharmaceuticals Product Solution and Service
3.5 Date of Enter into Psychotropic Pharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Psychotropic Pharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
5.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Psychotropic Pharmaceuticals Market Size (2015-2020)
6.2 Psychotropic Pharmaceuticals Key Players in North America (2019-2020)
6.3 North America Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
6.4 North America Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
7 Europe
7.1 Europe Psychotropic Pharmaceuticals Market Size (2015-2020)
7.2 Psychotropic Pharmaceuticals Key Players in Europe (2019-2020)
7.3 Europe Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
7.4 Europe Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
8 China
8.1 China Psychotropic Pharmaceuticals Market Size (2015-2020)
8.2 Psychotropic Pharmaceuticals Key Players in China (2019-2020)
8.3 China Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
8.4 China Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
9 Japan
9.1 Japan Psychotropic Pharmaceuticals Market Size (2015-2020)
9.2 Psychotropic Pharmaceuticals Key Players in Japan (2019-2020)
9.3 Japan Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
9.4 Japan Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Psychotropic Pharmaceuticals Market Size (2015-2020)
10.2 Psychotropic Pharmaceuticals Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
10.4 Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
11 India
11.1 India Psychotropic Pharmaceuticals Market Size (2015-2020)
11.2 Psychotropic Pharmaceuticals Key Players in India (2019-2020)
11.3 India Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
11.4 India Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Psychotropic Pharmaceuticals Market Size (2015-2020)
12.2 Psychotropic Pharmaceuticals Key Players in Central & South America (2019-2020)
12.3 Central & South America Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
12.4 Central & South America Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Details
13.1.2 Teva Pharmaceuticals Business Overview
13.1.3 Teva Pharmaceuticals Psychotropic Pharmaceuticals Introduction
13.1.4 Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020))
13.1.5 Teva Pharmaceuticals Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Psychotropic Pharmaceuticals Introduction
13.2.4 Novartis Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Psychotropic Pharmaceuticals Introduction
13.3.4 Mylan Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Psychotropic Pharmaceuticals Introduction
13.4.4 AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Sun Pharmaceuticals
13.5.1 Sun Pharmaceuticals Company Details
13.5.2 Sun Pharmaceuticals Business Overview
13.5.3 Sun Pharmaceuticals Psychotropic Pharmaceuticals Introduction
13.5.4 Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.5.5 Sun Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Psychotropic Pharmaceuticals Key Market Segments
Table 2. Key Players Covered: Ranking by Psychotropic Pharmaceuticals Revenue
Table 3. Ranking of Global Top Psychotropic Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-Depressants
Table 6. Key Players of Anti-Psychotics
Table 7. Key Players of Stimulants
Table 8. Key Players of Anxiolytics
Table 9. Key Players of Mood Stabilizers
Table 10. Global Psychotropic Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Psychotropic Pharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Psychotropic Pharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Psychotropic Pharmaceuticals Market Share by Regions (2015-2020)
Table 14. Global Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Psychotropic Pharmaceuticals Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Psychotropic Pharmaceuticals Market Growth Strategy
Table 20. Main Points Interviewed from Key Psychotropic Pharmaceuticals Players
Table 21. Global Psychotropic Pharmaceuticals Revenue by Players (2015-2020) (Million US$)
Table 22. Global Psychotropic Pharmaceuticals Market Share by Players (2015-2020)
Table 23. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2019)
Table 24. Global Psychotropic Pharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Psychotropic Pharmaceuticals Product Solution and Service
Table 27. Date of Enter into Psychotropic Pharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 30. Global Psychotropic Pharmaceuticals Market Size Share by Type (2015-2020)
Table 31. Global Psychotropic Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 32. Global Psychotropic Pharmaceuticals Market Size Share by Application (2015-2020)
Table 33. Global Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 34. Global Psychotropic Pharmaceuticals Market Size Share by Application (2021-2026)
Table 35. North America Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 37. North America Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 38. North America Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 39. North America Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 40. North America Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 41. Europe Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 43. Europe Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 45. Europe Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 47. China Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 48. China Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 49. China Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 50. China Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 51. China Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 52. China Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 53. Japan Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 55. Japan Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 57. Japan Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 61. Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 63. Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 65. India Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 66. India Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 67. India Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 68. India Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 69. India Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 70. India Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Psychotropic Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Psychotropic Pharmaceuticals Market Share (2019-2020)
Table 73. Central & South America Psychotropic Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Psychotropic Pharmaceuticals Market Share by Type (2015-2020)
Table 75. Central & South America Psychotropic Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Psychotropic Pharmaceuticals Market Share by Application (2015-2020)
Table 77. Teva Pharmaceuticals Company Details
Table 78. Teva Pharmaceuticals Business Overview
Table 79. Teva Pharmaceuticals Product
Table 80. Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (Million US$)
Table 81. Teva Pharmaceuticals Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Sun Pharmaceuticals Company Details
Table 98. Sun Pharmaceuticals Business Overview
Table 99. Sun Pharmaceuticals Product
Table 100. Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020) (Million US$)
Table 101. Sun Pharmaceuticals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychotropic Pharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Anti-Depressants Features
Figure 3. Anti-Psychotics Features
Figure 4. Stimulants Features
Figure 5. Anxiolytics Features
Figure 6. Mood Stabilizers Features
Figure 7. Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Retail Stores Case Studies
Figure 11. E-Commerce Case Studies
Figure 12. Psychotropic Pharmaceuticals Report Years Considered
Figure 13. Global Psychotropic Pharmaceuticals Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Psychotropic Pharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 15. Global Psychotropic Pharmaceuticals Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Psychotropic Pharmaceuticals Market Share by Players in 2019
Figure 18. Global Top Psychotropic Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Pharmaceuticals as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Psychotropic Pharmaceuticals Revenue in 2019
Figure 20. North America Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Psychotropic Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
医薬品・食品用偽造防止技術の世界市場（～2026年） Market Analysis and Insights: Global Pharmaceuticals and Food Anti-Counterfeiting Technologies Market The global Pharmaceuticals and Food Anti-Counterfeiting Technologies market size is projected to reach US$ 93130 million by 2026, from US$ 79820 million in 2020, at a CAGR of 15.4%% during 2021-2026…- 病院製剤の世界市場（～2026年） With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector. Market Analysis and Insights: Global Hospital Pharmaceuticals Market The global Hospital Pharmaceuticals market size is project…
- 抗がん剤の世界市場（～2026年） Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones. China and India are expected to of…
- 抗肥満処方の世界市場（～2026年） Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory …
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…